Q3 2024 EPS Estimates for Cross Country Healthcare, Inc. (NASDAQ:CCRN) Decreased by Analyst

Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Analysts at Barrington Research reduced their Q3 2024 EPS estimates for Cross Country Healthcare in a research report issued to clients and investors on Monday, May 6th. Barrington Research analyst K. Steinke now anticipates that the business services provider will post earnings of $0.15 per share for the quarter, down from their previous forecast of $0.26. Barrington Research currently has a “Outperform” rating and a $21.00 price objective on the stock. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $0.77 per share. Barrington Research also issued estimates for Cross Country Healthcare’s Q4 2024 earnings at $0.21 EPS, FY2024 earnings at $0.70 EPS and FY2025 earnings at $1.07 EPS.

Cross Country Healthcare (NASDAQ:CCRN) last released its quarterly earnings results on Wednesday, May 1st. The business services provider reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.02. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.69%. The firm had revenue of $379.17 million for the quarter, compared to analysts’ expectations of $374.38 million. During the same period in the prior year, the firm earned $0.84 EPS. The business’s revenue was down 39.1% on a year-over-year basis.

Several other research analysts have also recently weighed in on CCRN. Truist Financial lowered their price objective on Cross Country Healthcare from $22.00 to $16.00 and set a “hold” rating on the stock in a research report on Thursday, February 22nd. Benchmark lowered their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Finally, TheStreet downgraded shares of Cross Country Healthcare from a “b-” rating to a “c+” rating in a report on Friday, March 1st. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.83.

Cross Country Healthcare Trading Down 0.4 %

Shares of NASDAQ CCRN opened at $16.41 on Thursday. The business’s 50 day moving average is $17.78 and its 200-day moving average is $19.86. The firm has a market cap of $570.64 million, a P/E ratio of 12.62, a price-to-earnings-growth ratio of 2.17 and a beta of 0.77. Cross Country Healthcare has a 1-year low of $15.65 and a 1-year high of $28.75.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CCRN. GAMMA Investing LLC bought a new position in Cross Country Healthcare in the fourth quarter valued at approximately $28,000. Gladius Capital Management LP increased its stake in Cross Country Healthcare by 37.1% in the fourth quarter. Gladius Capital Management LP now owns 1,902 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 515 shares during the last quarter. Denali Advisors LLC increased its stake in Cross Country Healthcare by 3,885.5% in the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock valued at $103,000 after acquiring an additional 5,362 shares during the last quarter. Aigen Investment Management LP bought a new position in Cross Country Healthcare in the third quarter valued at approximately $219,000. Finally, Allspring Global Investments Holdings LLC increased its stake in Cross Country Healthcare by 212.9% in the first quarter. Allspring Global Investments Holdings LLC now owns 12,089 shares of the business services provider’s stock valued at $226,000 after acquiring an additional 8,225 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Karen Mote sold 6,216 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $16.95, for a total transaction of $105,361.20. Following the completion of the sale, the insider now owns 35,101 shares of the company’s stock, valued at approximately $594,961.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.90% of the company’s stock.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.